Mesa Laboratories (NASDAQ:MLAB) Sees Strong Trading Volume – What’s Next?

Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) saw unusually-high trading volume on Friday . Approximately 124,502 shares were traded during trading, a decline of 3% from the previous session’s volume of 128,801 shares.The stock last traded at $108.0950 and had previously closed at $107.35.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Mesa Laboratories currently has an average rating of “Reduce” and an average price target of $94.00.

Mesa Laboratories Stock Down 1.7%

The stock has a market capitalization of $582.78 million, a P/E ratio of 87.90 and a beta of 0.94. The firm’s 50-day simple moving average is $101.45 and its 200 day simple moving average is $90.15. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.29 and a current ratio of 1.72.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings data on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share for the quarter, missing the consensus estimate of $1.78 by ($0.25). The firm had revenue of $63.72 million for the quarter, compared to analyst estimates of $65.21 million. Mesa Laboratories had a return on equity of 20.96% and a net margin of 2.69%.During the same quarter in the prior year, the firm earned ($1.31) earnings per share.

Mesa Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Friday, May 29th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, May 29th. This represents a $0.64 annualized dividend and a dividend yield of 0.6%. Mesa Laboratories’s payout ratio is currently 53.33%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Boston Partners increased its stake in shares of Mesa Laboratories by 86.6% during the 4th quarter. Boston Partners now owns 213,376 shares of the medical instruments supplier’s stock worth $16,752,000 after purchasing an additional 99,019 shares during the last quarter. Simcoe Capital Management LLC acquired a new position in shares of Mesa Laboratories during the 3rd quarter worth about $12,794,000. Royce & Associates LP increased its stake in shares of Mesa Laboratories by 3.2% during the 4th quarter. Royce & Associates LP now owns 153,352 shares of the medical instruments supplier’s stock worth $12,038,000 after purchasing an additional 4,794 shares during the last quarter. Kennedy Capital Management LLC increased its stake in shares of Mesa Laboratories by 19.0% during the 4th quarter. Kennedy Capital Management LLC now owns 144,606 shares of the medical instruments supplier’s stock worth $11,352,000 after purchasing an additional 23,060 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. increased its stake in shares of Mesa Laboratories by 15.1% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 141,973 shares of the medical instruments supplier’s stock worth $11,145,000 after purchasing an additional 18,592 shares during the last quarter. 90.60% of the stock is currently owned by institutional investors and hedge funds.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.